COR · Cencora, Inc.
$331.00
-2.21% last session
End-of-day data · close of 2026-10-23
Market cap
$63B
Enterprise value
$75B
Trailing P/E
24.6
Forward P/E
16.8
Dividend yield
1.0%
Beta
0.58
Avg volume
1M
Employees
47K
Daily Change %
-2.21%
5 Days Change
-0.72%
10 Days Change
2.54%
30 Days Change
8.39%
60 Days Change
4.54%
Month to Day Change
9.26%
Year to Day Change
0.81%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — COR
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-22
Latest call per bank · past 12 months
UBS
Buy$400
+20.8% vs priceRBC Capital
Sector Perform$330
-0.3% vs priceWells Fargo
Overweight$395
+19.3% vs priceMorgan Stanley
Overweight$346
+4.5% vs priceJP Morgan
Overweight$390
+17.8% vs priceBank of America
Neutral$285
-13.9% vs priceBarclays
Overweight$350
+5.7% vs priceCitigroup
Buy$355
+7.3% vs priceJefferies
Buy$440
+32.9% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Baird | Maintains | Outperform | $373 → $375 |
| 2026-10-20 | Argus Research | Maintains | Buy | $340 → $380 |
| 2026-10-16 | UBS | Maintains | Buy | $430 → $400 |
| 2026-10-07 | Leerink Partners | Maintains | Outperform | $380 → $388 |
| 2026-09-08 | RBC Capital | Reiterates | Sector Perform | $330 |
| 2026-08-19 | RBC Capital | Initiates | Sector Perform | $0.00 → $330 |
| 2026-08-11 | Wells Fargo | Maintains | Overweight | $331 → $395 |
| 2026-08-07 | Morgan Stanley | Maintains | Overweight | $342 → $346 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 54 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 2.8% above the 50-day MA ($322.04).
- bullish: Price vs 200-day MA: Trading 4.6% above the 200-day MA ($316.56).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+1.15) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($251.67) and high ($372.53).
COR Price Chart
Loading chart for COR…
Fundamentals
About Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
More in Medical Distribution
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.